Nodular sclerosis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Nodular sclerosis Classification and external resources | |
| ICD-10 | C81.1 |
|---|---|
| ICD-9 | 201.5 |
| ICD-O: | 9663/3-9667/3 |
|
WikiDoc Resources for Nodular sclerosis | |
|
Articles | |
|---|---|
|
Most recent articles on Nodular sclerosis Most cited articles on Nodular sclerosis | |
|
Media | |
|
Powerpoint slides on Nodular sclerosis | |
|
Evidence Based Medicine | |
|
Cochrane Collaboration on Nodular sclerosis | |
|
Clinical Trials | |
|
Ongoing Trials on Nodular sclerosis at Clinical Trials.gov Trial results on Nodular sclerosis Clinical Trials on Nodular sclerosis at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Nodular sclerosis NICE Guidance on Nodular sclerosis
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Nodular sclerosis Discussion groups on Nodular sclerosis Patient Handouts on Nodular sclerosis Directions to Hospitals Treating Nodular sclerosis Risk calculators and risk factors for Nodular sclerosis
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Nodular sclerosis | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Nodular sclerosis (or "NSHL") is a form of Hodgkin's lymphoma which is the most common subtype of HL in developed countries. It usually affects females more than males and has a median age of onset at ~28 years. It is composed of large tumor nodules with lacunar Reed-Sternberg cell (RS cells) surrounded by fibrotic collagen bands.
The British National Lymphoma Investigation further categorized NSHL based upon Reed-Sternberg cells into "nodular sclerosis type I" (NS I) and "nodular sclerosis type II" (NS II), with the first subtype responding better to treatment. [1]
Reference
- ↑ Mauch, Peter; James Armitage, Volker Diehl, Richard Hoppe, Laurence Weiss (1999). Hodgkin's Disease. Lippincott Williams & Wilkins, 107. ISBN 0-7817-1502-4.
External links
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
